IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia

Completed · Phase 3 · Has a placebo group

Conditions studied: Cervical Dystonia

In brief

At baseline patients received incobotulinumtoxinA (Xeomin) or placebo. Thereafter, all patients who entered the extension period were treated with up to five injection sessions of incobotulinumtoxinA (Xeomin) during the extension period.

Key facts

Study ID

NCT00407030

Run by

Merz Pharmaceuticals GmbH

People needed

233

Starts

2006-07-01

Expected to finish

2009-06-01

Last updated by the study team

2013-07-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.